Brian Wei

Brian Wei joined Sanofi in 2021 as Senior Scientist and managing a Separation Science subgroup in BioProcess Analytics under Global CMC Development. Brian is responsible for managing a group to support various bioprocess testing and leading the separation science innovation to address the future analytical challenges. Before joining Sanofi, Brian worked for Sciex, ProteinSimple, and BioVidria focusing on developing new separation technologies for new bio-instrumentations. During the academic years, Brian has collaborated with multiple companies in instrumentation and microfluidic devices and collaborated with several pharma companies, Mayo Clinic for analytical development using new technologies. Brian earned a B.S. in Chemistry from the University of Detroit Mercy, a M.S in Chemistry (Organocatalysis) from Oakland University and a Ph.D. in Chemistry (Analytical/Organic/Chemical biology) from Purdue University. Brian has been invited to present the topic ‘N-glycan analytical assay development for new protein-based modalities’ in the Analytical Development of New Drug Modalities special session at Pittcon 2024.